Secretary of Health and Human Services Xavier Becerra said the administration is willing to do whatever it takes to protect access to the abortion drug mifepristone, after a federal judge in Texas suspended the FDA’s approval of the medication on Friday. As my colleague Madison Pauly reported, the ruling could have “potentially explosive implications for the availability of abortion nationwide, regardless of state laws and policies.” In a conflicting ruling the same day, a federal judge in Washington state ruled that the FDA should not make any changes to access to mifepristone, though it remains unclear what the result of the dueling orders will be.